Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

788 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research. Celli BR, et al. Among authors: wise ra. Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315. Eur Respir Rev. 2015. PMID: 26028628 Free PMC article. Review.
Impact of Clinical Characteristics and Biomarkers on AIRQ Exacerbation Prediction Ability.
Murphy KR, Beuther DA, Chipps B, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Ross M, Coyne KS, Zeiger RS. Murphy KR, et al. Among authors: wise ra. J Allergy Clin Immunol Pract. 2024 May 3:S2213-2198(24)00436-7. doi: 10.1016/j.jaip.2024.04.050. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 38705273
Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire.
Chipps BE, Zeiger RS, Beuther DA, Wise RA, McCann W, Reibman J, George M, Gilbert I, Eudicone JM, Coyne KS, Harding G, Murphy KR. Chipps BE, et al. Among authors: wise ra. Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00153-4. doi: 10.1016/j.anai.2024.03.011. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 38494113 Free article.
FEV1Q: a race-neutral approach to assessing lung function.
Balasubramanian A, Wise RA, Stanojevic S, Miller MR, McCormack MC. Balasubramanian A, et al. Among authors: wise ra. Eur Respir J. 2024 Apr 4;63(4):2301622. doi: 10.1183/13993003.01622-2023. Print 2024 Apr. Eur Respir J. 2024. PMID: 38485146 Free PMC article.
Assessing meaningful change in the Asthma Impairment and Risk Questionnaire.
McCann W, Murphy KR, Zeiger RS, Beuther DA, Wise RA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Cutts K, Coyne KS, Chipps B. McCann W, et al. Among authors: wise ra. Ann Allergy Asthma Immunol. 2024 Feb 17:S1081-1206(24)00085-1. doi: 10.1016/j.anai.2024.02.013. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 38369256 Free article.
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
Fowler VG Jr, Das AF, Lipka-Diamond J, Ambler JE, Schuch R, Pomerantz R, Cassino C, Jáuregui-Peredo L, Moran GJ, Rupp ME, Lachiewicz AM, Kuti JL, Wise RA, Kaye KS, Zervos MJ, Nichols WG. Fowler VG Jr, et al. Among authors: wise ra. Clin Infect Dis. 2024 Jan 31:ciae043. doi: 10.1093/cid/ciae043. Online ahead of print. Clin Infect Dis. 2024. PMID: 38297916
788 results